MEDI9447, a human monoclonal antibody specific to CD73, increased the infiltration of effector CD8+T cells and macrophages in mouse models, alleviated adenosine-mediated lymphocyte inhibition in vitro, and inhibited isogenic tumor growth in mice (43). Here, NT5E is linked to neoplasm.